Onward Medical N.V. (ONWD.BR)
EUR 4.74
(-0.21%)
EUR 4.74
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 532 Thousand | 2.14 Million | 1.39 Million | 800 Thousand | 554 Thousand | 474 Thousand |
| Cost of Revenue | 15.35 Million | 14.68 Million | 4.04 Million | 2.3 Million | 838 Thousand | 1.04 Million |
| Gross Profit | -14.81 Million | -12.53 Million | -2.64 Million | -1.5 Million | -284 Thousand | -567 Thousand |
| Operating Expenses | 20.64 Million | 17.34 Million | 24.48 Million | 13.2 Million | 9.93 Million | 7.36 Million |
| Selling, General and Administrative Expenses | 15.73 Million | 10.02 Million | 7.75 Million | 3.06 Million | 2.5 Million | 1.34 Million |
| Research and Development Expenses | 13.84 Million | 13.13 Million | 7.93 Million | 5.82 Million | 5.35 Million | 4.72 Million |
| Other Expenses | -8.93 Million | 7.31 Million | 8.79 Million | 4.31 Million | 2.07 Million | 1.29 Million |
| Cost and Expenses | 35.99 Million | 32.02 Million | 28.53 Million | 15.51 Million | 10.77 Million | 8.4 Million |
| Operating Income | -35.46 Million | -32.02 Million | -28.53 Million | -15.51 Million | -10.77 Million | -8.4 Million |
| Interest Expense | 600 Thousand | 1.51 Million | 5.59 Million | 4.43 Million | 2.67 Million | 1.48 Million |
| Income Tax Expense | 107 Thousand | -766 Thousand | 69 Thousand | 20 Thousand | 39 Thousand | 18 Thousand |
| Earnings before Tax | -36.07 Million | -33.53 Million | -34.24 Million | -19.99 Million | -13.44 Million | -9.89 Million |
| Net Income | -36.18 Million | -32.77 Million | -34.31 Million | -20.01 Million | -13.48 Million | -9.91 Million |
| Earnings Per Share Basic | -1.20 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| Earnings Per Share Diluted | -1.20 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| Weighted Average Shares Outstanding | 30.15 Million | 30.18 Million | 30.18 Million | 20.82 Million | 20.82 Million | 20.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.18 Million | 30.18 Million | 30.18 Million | 20.82 Million | 20.82 Million | 20.82 Million |
| Gross Margin | -27.85 | -5.84 | -1.89 | -1.89 | -0.51 | -1.20 |
| EBIT Margin | -66.23 | -14.57 | -20.24 | -19.12 | -19.03 | -17.24 |
| Profit Margin | -68.01 | -15.26 | -24.53 | -25.02 | -24.34 | -20.91 |
| EBITDA | -35.23 Million | -31.25 Million | -28.3 Million | -15.29 Million | -10.54 Million | -8.17 Million |
| Earnings Before Tax Margin | -66.66 | -14.91 | -20.39 | -19.39 | -19.44 | -17.73 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 104 Thousand | 104 Thousand | 532 Thousand | -198 Thousand | -214 Thousand | 464 Thousand |
| Cost of Revenue | 3.34 Million | 3.34 Million | 726 Thousand | 3.38 Million | 13.7 Million | 329 Thousand |
| Gross Profit | -3.23 Million | -3.23 Million | -194 Thousand | -3.57 Million | -13.92 Million | 135 Thousand |
| Operating Expenses | 6.13 Million | 6.13 Million | 35.26 Million | 4.76 Million | 5.26 Million | 19.37 Million |
| Selling, General and Administrative Expenses | 4.79 Million | 4.79 Million | - | 3.39 Million | 4.47 Million | 11.74 Million |
| Research and Development Expenses | 3.06 Million | 3.06 Million | - | 3.1 Million | 3.81 Million | 7.63 Million |
| Other Expenses | -1.72 Million | -1.72 Million | -36 Million | -1.73 Million | - | - |
| Cost and Expenses | 9.47 Million | 9.47 Million | 35.99 Million | 8.14 Million | 18.96 Million | 19.7 Million |
| Operating Income | -9.37 Million | -9.37 Million | -35.99 Million | -8.34 Million | -8.35 Million | -19.7 Million |
| Interest Expense | - | - | 600 Thousand | 143 Thousand | - | 457 Thousand |
| Income Tax Expense | 159 Thousand | 159 Thousand | 107 Thousand | 31 Thousand | 27.5 Thousand | 45 Thousand |
| Earnings before Tax | -9.28 Million | -9.28 Million | -36.07 Million | -8.41 Million | -8.43 Million | -19.23 Million |
| Net Income | -9.12 Million | -9.12 Million | -36.18 Million | -8.44 Million | -8.45 Million | -19.28 Million |
| Earnings Per Share Basic | -0.27 | -0.27 | - | -0.28 | -0.28 | -0.64 |
| Earnings Per Share Diluted | -0.26 | -0.26 | - | -0.28 | -0.28 | -0.64 |
| Weighted Average Shares Outstanding | 34.43 Million | 34.43 Million | 30.18 Million | 30.17 Million | 30.18 Million | 30.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.62 Million | 34.62 Million | 30.18 Million | 30.18 Million | 30.18 Million | 30.18 Million |
| Gross Margin | -31.12 | -31.12 | -0.36 | 18.08 | 65.05 | 0.29 |
| EBIT Margin | -88.05 | -88.05 | - | 41.84 | 38.30 | -41.77 |
| Profit Margin | -87.75 | -87.75 | -68.01 | 42.67 | 39.53 | -41.56 |
| EBITDA | -9.15 Million | -9.15 Million | - | -8.28 Million | -8.19 Million | -19.37 Million |
| Earnings Before Tax Margin | -90.14 | -90.14 | -67.66 | 42.13 | 39.07 | -42.47 |
000338
VLVLY
LIME
600261
CLIME-B
BRE